Clinical Trial Update: A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy [Phase 2]

View source ↗

Summary

Clinical trial update indicates a Phase 2 long-term safety study of HRS-1893 for hypertrophic cardiomyopathy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• HRS-1893

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Hypertrophic Cardiomyopathy | Phase 2 | Status: RECRUITING